1 / 6

Spasticity Pipeline Review H1 2015

This report provides comprehensive information on the therapeutic development for Spasticity, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Spasticity and special features on late-stage and discontinued projects.

jack2222simon
Télécharger la présentation

Spasticity Pipeline Review H1 2015

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Spasticity - Pipeline Review, H1 2015 By RnRMarketResearch.com Publisher Name : Global Markets Direct Date: 29-May-2015 No. of pages: 85 Single User License: US $2000 Browse more Reports on Therapeutics at http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals/therapeutics ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441

  2. Spasticity - Pipeline Review, H1 2015 This report gives far reaching data on the helpful advancement for Spasticity, complete with relative examination at different stages, therapeutics evaluation by medication target, system of activity (MoA), course of organization (RoA) and particle sort, alongside most recent upgrades, and highlighted news and press discharges. It additionally audits key players included in the helpful improvement for Spasticity and exceptional elements on late-stage and stopped ventures. The report improves choice making capacities and help to make compelling counter procedures to increase upper hand. It fortifies R&D pipelines by distinguishing new targets and MOAs to deliver first-in-class and best-in-class items. ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441

  3. Spasticity - Pipeline Review, H1 2015 Companies Discussed/Mentioned in this Research : Addex Therapeutics Ltd, Canbex Therapeutics Ltd., Concert Pharmaceuticals, Inc., Daewoong Pharmaceutical Co., Ltd., Echo Pharmaceuticals B.V., GW Pharmaceuticals plc, Ipsen S.A., Merz Pharma GmbH & Co. KgaA, OBI Pharma, Inc., Osmotica Pharmaceutical Corp., SanochemiaPharmazeutika AG, SciFluor Life Sciences, LLC and Sun Pharma Advanced Research Company Ltd. Drugs Profile Discussed in this Research : abobotulinumtoxin A, ADX-71441, arbaclofen ER, baclofen ER, CTP-354, dronabinol, incobotulinumtoxin A, nabiximols, NB-2221, OBI-858, onabotulinumtoxin A, Small Molecule for Spasticity, tolperisone and VSN-16R ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441

  4. Spasticity - Pipeline Review, H1 2015 Scope For Spasticity - Pipeline Review, H1 2015 • The report provides a snapshot of the global therapeutic landscape of Spasticity • The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities • The report reviews key players involved in the therapeutics development for Spasticity and enlists all their major and minor projects • The report summarizes all the dormant and discontinued pipeline projects • A review of the Spasticity products under development by companies and universities/research institutes based on information derived from company and industry-specific sources • Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages • A detailed assessment of monotherapy and combination therapy pipeline projects ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441

  5. Spasticity - Pipeline Review, H1 2015 Reasons to Buy: • Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage • Develop strategic initiatives by understanding the focus areas of leading companies • Identify and understand important and diverse types of therapeutics under development for Spasticity • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline • Devise corrective measures for pipeline projects by understanding Spasticity pipeline depth and focus of Indication therapeutics ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441

  6. Spasticity - Pipeline Review, H1 2015 For more details contact Mr. Ritesh Tiwari :sales@rnrmarketresearch.com/ +18883915441 RnRMarkertResearch RnRMarketResearch.com, an online repository of market  research reports, offers in-depth analysis of over 5000 market segments. RnRMarket Research library has syndicated reports by leading market research  publishers across the globe. ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441

More Related